Julie Feder is the founder of Aura Biosciences. Aura Biosciences has raised $40M in total funding. Latest round: Series D. Backed by Medicxi.
Julie Feder is the Chief Financial Officer at Aura Biosciences, a company focused on developing targeted therapies in ocular oncology. She joined Aura Biosciences in September 2018, bringing over four decades of experience in financial management to the leadership team. Her role involves overseeing the company's financial operations, particularly as it moves into late-stage clinical development.
Full founder directory · Investor directory · Company funding database · Fundraising library